MENGENAI EPISOD INI

Bahasa Inggeris
Amerika Syarikat

TRANSKRIP 🔗

CARI EPISOD LEPAS

Cari episod lepas bagi IBCD 2016.

EPISOD LAIN DALAM PODCAST INI

Dr Golfinopoulos meets with ecancertv at IBCD 2016 to discuss SPECTA: a screening platform that sought to encourage patients to participate in clinical trials. He describes how regulatory involvement in trial design and drug design could be streamlined, and the issue of reimbursement for person ...
Dr Malik speaks with ecancertv at IBCD 2016 to discuss the work of the National Cancer Institute in recruiting patients to clinical trials when subtyping limits disease-wide enrollment. She describes how 'exceptional responders' can be referred to the NCI for genotyping, and schemes to match pa ...
Dr Schneider speaks with ecancertv at IBCD 2016 about the regulatory checkpoints to be passed in the development of assays. He highlights the difference in reproducibility and robustness of research and clinical assays, the clinical utility of validated biomarkers, and how beginning assay devel ...
Dr Beer speaks with ecancertv at IBCD 2016 about making use of genomic data in a clinically actionable setting. He opens with comments on the work of Dr Moritz Gerstung and considers the issues of storage, access and regulation in genomic libraries. Dr Beer describes how unregulated access and ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada ecancer.org, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.